计算技术在抗体fc融合分子设计中的应用,用于治疗
Chong Lee Ng1, Theam Soon Lim1, Yee Siew Choong2
1Institute for Research in Molecular Medicine (INFORMM), Universiti Sains Malaysia, Minden, Penang, Malaysia.
Molecular biotechnology
|September 24, 2023
概括
计算技术增强了抗体工程,特别是Fc区域,优化治疗效果和降低剂量. 这种方法指导了新型Fc合疗法的合理设计.
科学领域:
- 生物技术是生物技术.
- 免疫学 免疫学 免疫学
- 计算生物学 计算生物学
背景情况:
- 1975年开发的混合瘤技术于1986年导致了第一个批准的单克隆抗体.
- 抗体工程已经超越了可变域,包括碎片结晶 (Fc) 区域.
- Fc区域工程影响免疫反应,血清半衰期,治疗剂量和细胞介导的细胞毒性/细胞化.
研究的目的:
- 通过使用计算技术,回顾Fc融合分子设计的最新进展.
- 总结 in silico 方法在设计和分析 Fc 聚变分子的治疗应用中的实用性.
主要方法:
- 关于Fc融合分子设计的最新文献的综述.
- 专注于在抗体工程中集成计算技术.
- 对Fc融合分子开发的in silico方法的分析.
主要成果:
- 计算技术可以产生假设,并指导合理的抗体设计.
- 工程Fc区域提供了对抗体效应器功能和药理动力学的显著控制.
- 在Fc合疗法的设计和分析中,in silico工具是有价值的.
结论:
- 计算方法是现代抗体工程中不可或缺的组成部分,特别是对于Fc融合分子.
- 在 silico 方法有助于合理设计 Fc 融合的治疗药物,以提高疗效和安全性.
- 计算技术的战略性使用加速了基于抗体的新疗法的发展.
相关概念视频
Hybridoma Technology
14.9K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
14.9K
Antibody Actions
1.1K
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
1.1K


